Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis.
Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
Other National MS Societies (Not listed here)
Randomized study combining interferon & glatiramer acetate in multiple sclerosis.
Predictors of Fatigue Impact in Persons With Long-Standing Multiple Sclerosis.
17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
Masitinib in Patients with Primary Progressive Multiple Sclerosis (PPMS) or Relapse-Free Secondary Multiple Sclerosis (SPMS)
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE.
8th World Congress on Controversies in Neurology (CONy)
Pharmacokinetics and metabolism of mitoxantrone. A review.
Keystone Symposium: Innate Immunity and Determinants of Microbial Pathogenesis - joint with - Mechanisms of Pro-Inflammatory Diseases
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
From High- to Low-Frequency Administered Interferon-Beta for Multiple Sclerosis: A Multicenter Study.
Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
Multiple sclerosis prevalence in the United States commercially insured population.
Episode 14 with Professor Gavin Giovannoni on the Epstein-Barr Virus (EBV).
Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Episode 15 with Professor Ludwig Kappos on the DECIDE trial of daclizumab versus interferon ë_-1a
Novel MS Drugs Advance
endMS CONFERENCE
Effirma, Synthetic Biologics
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.
Sex hormones and multiple sclerosis: another informative failure.

Pages